The American College of Obstetrics & Gynecology reiterated their official statement in 2017 that buprenorphine is the recommendation for treatment of addiction in pregnancy.


Guidelines and recommendations from the Substance Abuse and Mental Health Services Administration regarding addiction treatment in pregnancy.


The genetic polymorphisms of OPRM1 and COMT were associated with decreased hospital stays in infants diagnosed with NAS.


The official Finnegan Neonatal Abstinence Scoring Tool used universally in NICUs.


A meta-analysis showing no association between methadone dose and NAS severity.


A retrospective study from 2000-2009 about the overall cost of NAS in the US. Average cost of stay in 2009 was $53,400, and 77.6% of stays were billed to Medicaid.


Official guidelines from the Substance Abuse and Mental Health Services Administration regarding buprenorphine as the recommended treatment in OUD and to not taper pregnant patients.


The specific needs of women who suffer from substance abuse are addressed in this comprehensive overview with specific guidelines from the Substance Abuse and Mental Health Services Administration.


An interesting study of attempting to force taper and detox patients during pregnancy that showed a significant increase in NAS rates. This study contributed to the ACOGs further recommendations for continued treatment with buprenorphine in pregnancy for addiction.


A large review of literature from the past 50 years about the higher rates of relapse and no improvement of newborn health in pregnant women who have gone through detoxification.


High Point Clinic's Dr. Vance Shaw, MD reviews NAS.


A review of over 1,600 articles from the American Society of Addiction Medicine in 2017 about treating addiction in pregnancy.


Concomitant use of methadone with benzodiazepines increases rates of NAS and length of hospital stay.


High Point Clinic's Dr. Vance Shaw, MD offers evidence-based guidelines on treating pregnant patients with OUD.


In a large review of research comparing buprenorphine and methadone in pregnancy, buprenorphine was shown to be superior in both maternal and fetal outcomes.


A powerpoint presentation on effective Finnegan scoring and how to assure accurate scoring across providers.


A powerful study from the New England Journal of Medicine that showed superiority of buprenorphine over methadone in pregnancy with decreased rates of NAS and shorter hospital stays.


Detoxification is possible during pregnancy, but requires significant resources and is not the recommendation by all official organizations.


A look at if there is an association between opioid detoxification during pregnancy and fetal distress or death as well as maternal relapse.


Recommendations from the CDC that breastfeeding is safe in patients with HCV and/or HBV. There is insufficient data to conclude recommendations on safety in cracked or bleeding nipples.


In a meta-analysis, buprenorphine shows to be superior to methadone in pregnancy.


An overview with recommendations from the American Academy of Pediatrics on neonatal drug withdrawal.


An extensive review with recommendations on all aspects of treating OUD in pregnancy from the Substance Abuse and Mental Health Services Administration.


A brief overview of OUD and treatment options for pregnant patients.

© 2018 by Evidence Based Addiction Medicine dba High Point Clinic

Tel: 423.631.0731

  • White Facebook Icon